Jacob I. Contreras
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 1
-
- Cancer-related Molecular Pathways 3
-
- Cell death mechanisms and regulation 2
- Cancer therapeutics and mechanisms 1
-
- Synthesis and biological activity 2
-
- Bioactive Compounds and Antitumor Agents 2
-
- Advanced Breast Cancer Therapies 3
-
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Amarnath NatarajanSandeep RanaYogesh A. SonawaneMargaret TaylorCaroline M. RobbSmit KourMohammad AbidDaryl J. Murry
- Cited by
- HematologyOncologyMolecular Biology
- Journals
- Oncotarget (3 papers)Journal of Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Jacob I. Contreras
12 papers receiving 527 citations
Peers
Comparison fields: 5 of 54
- Hematology 80
- Oncology 195
- Molecular Biology 344
- Organic Chemistry 124
- Toxicology 13
Countries citing papers authored by Jacob I. Contreras
This map shows the geographic impact of Jacob I. Contreras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob I. Contreras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob I. Contreras more than expected).
Fields of papers citing papers by Jacob I. Contreras
This network shows the impact of papers produced by Jacob I. Contreras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob I. Contreras. The network helps show where Jacob I. Contreras may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacob I. Contreras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 13 | |
| 2 | 2020 | 13 | |
| 3 | 2020 | 3 | |
| 4 | 2019 | 21 | |
| 5 | 2018 | 12 | |
| 6 | 2017 | 177 | |
| 7 | 2017 | 21 | |
| 8 | 2017 | 25 | |
| 9 | 2017 | 23 | |
| 10 | 2017 | 6 | |
| 11 | 2016 | 124 | |
| 12 | 2016 | 98 |
About Jacob I. Contreras
Jacob I. Contreras is a scholar working on Toxicology, Genetics and Cell Biology, having authored 12 papers that have together received 536 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer-related Molecular Pathways (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Cell death mechanisms and regulation (2 papers), Synthesis and biological activity (2 papers), Cancer therapeutics and mechanisms (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (80 citations), Oncology (195 citations) and Molecular Biology (344 citations). Jacob I. Contreras has collaborated with scholars based in United States and China. Frequent co-authors include Amarnath Natarajan, Sandeep Rana, Yogesh A. Sonawane, Margaret Taylor, Caroline M. Robb, Smit Kour, Mohammad Abid, Daryl J. Murry, Muhammad Zahid and Smitha Kizhake. Their work appears in journals such as Oncotarget, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Chemical Communications and Macromolecular Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.